Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0087 | 0.0949 | 0.0949 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0087 | 0.0949 | 0.0949 |
Mycobacterium leprae | PROBABLE 1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE DXR (DXP REDUCTOISOMERASE) (1-DEOXYXYLULOSE-5-PHOSPHATE REDUCTOISOMERAS | 0.0425 | 0.573 | 1 |
Entamoeba histolytica | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.0022 | 0.0022 | 0.0022 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0024 | 0.0048 | 0.0309 |
Treponema pallidum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.0425 | 0.573 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0728 | 1 | 1 |
Giardia lamblia | Malate dehydrogenase | 0.0042 | 0.0308 | 1 |
Toxoplasma gondii | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.0425 | 0.573 | 1 |
Trypanosoma cruzi | cytosolic malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0087 | 0.0949 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Plasmodium falciparum | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.0425 | 0.573 | 0.5 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Brugia malayi | RNase H family protein | 0.0022 | 0.0022 | 0.0235 |
Trypanosoma brucei | unspecified product | 0.0024 | 0.0048 | 0.0309 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0024 | 0.0048 | 0.0309 |
Mycobacterium ulcerans | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.0425 | 0.573 | 1 |
Trypanosoma cruzi | cytosolic malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Echinococcus multilocularis | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.0949 | 0.0949 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Wolbachia endosymbiont of Brugia malayi | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.0425 | 0.573 | 1 |
Leishmania major | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0087 | 0.0949 | 0.0949 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.0022 | 0.0022 | 0.5 |
Echinococcus granulosus | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Brugia malayi | RNase H family protein | 0.0022 | 0.0022 | 0.0235 |
Trypanosoma brucei | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 0.3378 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Plasmodium vivax | 1-deoxy-D-xylulose 5-phosphate reductoisomerase, putative | 0.0425 | 0.573 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.0949 | 0.0949 |
Schistosoma mansoni | apoptosis regulator bax | 0.0087 | 0.0949 | 0.0949 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Schistosoma mansoni | malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0024 | 0.0048 | 0.0309 |
Schistosoma mansoni | phosphoglucomutase | 0.0022 | 0.0022 | 0.0022 |
Echinococcus granulosus | ribonuclease H1 | 0.0022 | 0.0022 | 0.0022 |
Mycobacterium tuberculosis | Probable 1-deoxy-D-xylulose 5-phosphate reductoisomerase Dxr (DXP reductoisomerase) (1-deoxyxylulose-5-phosphate reductoisomeras | 0.0102 | 0.1161 | 1 |
Chlamydia trachomatis | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0.0425 | 0.573 | 1 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0087 | 0.0949 | 0.0949 |
Trypanosoma brucei | RNA helicase, putative | 0.0082 | 0.0869 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.0949 | 1 |
Trichomonas vaginalis | malate and lactate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Echinococcus multilocularis | ribonuclease H1 | 0.0022 | 0.0022 | 0.0022 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Echinococcus multilocularis | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0728 | 1 | 1 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0033 | 0.018 | 0.5845 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0087 | 0.0949 | 0.0949 |
Schistosoma mansoni | malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Schistosoma mansoni | phosphoglucomutase | 0.0022 | 0.0022 | 0.0022 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0087 | 0.0949 | 1 |
Echinococcus granulosus | expressed protein | 0.0394 | 0.5278 | 0.5278 |
Echinococcus granulosus | cytosolic malate dehydrogenase | 0.0042 | 0.0308 | 0.0308 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.0022 | 0.0022 | 0.0721 |
Entamoeba histolytica | malate dehydrogenase,cytoplasmic, putative | 0.0042 | 0.0308 | 1 |
Brugia malayi | Malate dehydrogenase, cytoplasmic | 0.0042 | 0.0308 | 0.3251 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0024 | 0.0048 | 0.0309 |
Loa Loa (eye worm) | malate dehydrogenase | 0.0042 | 0.0308 | 0.3251 |
Echinococcus multilocularis | expressed protein | 0.0394 | 0.5278 | 0.5278 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.0869 | 0.0869 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.0949 | 0.0949 |
Brugia malayi | RNase H family protein | 0.0022 | 0.0022 | 0.0235 |
Trichomonas vaginalis | malate dehydrogenase, putative | 0.0042 | 0.0308 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.